Bruce A. Freeman
Directeur Général chez Creegh Pharmaceuticals, Inc.
Profil
Bruce A.
Freeman is the founder of Complexa, Inc. founded in 2008.
He is currently the President, Chief Executive Officer & Director at Creegh Pharmaceuticals, Inc. and also serves as the Chairman-Department of Pharmacology at the University of Pittsburgh.
Dr. Freeman received his undergraduate and doctorate degrees from the University of California, Riverside.
Postes actifs de Bruce A. Freeman
| Sociétés | Poste | Début |
|---|---|---|
| University of Pittsburgh | Corporate Officer/Principal | - |
Creegh Pharmaceuticals, Inc.
 Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Directeur Général | - |
Anciens postes connus de Bruce A. Freeman
| Sociétés | Poste | Fin |
|---|---|---|
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Fondateur | - |
Formation de Bruce A. Freeman
| University of California, Riverside | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
Creegh Pharmaceuticals, Inc.
Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Health Technology |